The Board of Directors of BONESUPPORT HOLDING AB (“BONESUPPORT”) has, pursuant to the authorization granted by the 2026 annual general meeting, resolved to initiate a share buy-back program of up to SEK 100 million for the purpose of adapting BONESUPPORT’s capital structure to the company’s capital needs and thereby contribute to increased shareholder value. The program commences at the earliest on September 1, 2026 and will end at the latest on October 30, 2026.
The acquisition of ordinary shares will be carried out in accordance with the Market Abuse Regulation (EU) 596/2014 ("MAR") and the European Commission's Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The acquisition of shares will be managed by DNB Carnegie Investment Bank AB that will make its own trading decisions regarding the timing of the acquisitions independently of BONESUPPORT.
The Board of Directors intends to propose that the acquired shares be cancelled through a reduction of BONESUPPORT’s share capital at the next Annual General Meeting.
The following terms and conditions apply to the acquisitions of shares:
As per September 1, 2026, the total number of shares in BONESUPPORT is 66,764,350, of which 65,859,195 are ordinary shares and 905,155 are Series C shares. BONESUPPORT’s holdings of treasury shares amount to 373,320 ordinary shares and 905,155 Series C shares as per the same date.